$15.1225
-0.2675[-1.74%]
At close: Apr 16
$15.1225
0[0.00%]
After Hours: 4:52PM EDT
Catalyst Pharmaceuticals
(NASDAQ:CPRX)Overview Rating
Speculative
Catalyst Pharmaceuticals Stock (NASDAQ:CPRX), Quotes and News Summary
Catalyst Pharmaceuticals Stock (NASDAQ: CPRX) stock price, news, charts, stock research, profile.
| Open | $15.220 |
| Close | $15.540 |
| Volume / Avg. | 919.170K / 1.282M |
| Day Range | 15.158 - 15.690 |
| 52 Wk Range | 11.090 - 18.220 |
| Market Cap | $1.785B |
| P/E Ratio | 24.429 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 6.38% |
| Days to Cover | 5.28 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Catalyst Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercial...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Catalyst Pharmaceuticals (CPRX) stock?
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) through any online brokerage.
Who are Catalyst Pharmaceuticals's (CPRX) competitors?
Other companies in Catalyst Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Catalyst Pharmaceuticals (CPRX) stock?
The latest price target for Catalyst Pharmaceuticals (NASDAQ: CPRX) was reported by Oppenheimer on Wednesday, March 27, 2024. The analyst firm set a price target for 29.00 expecting CPRX to rise to within 12 months (a possible 91.77% upside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Pharmaceuticals (CPRX)?
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $15.1225 last updated Today at April 16, 2024 at 4:52 PM EDT.
Does Catalyst Pharmaceuticals (CPRX) pay a dividend?
There are no upcoming dividends for Catalyst Pharmaceuticals.
When is Catalyst Pharmaceuticals (NASDAQ:CPRX) reporting earnings?
Catalyst Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
Is Catalyst Pharmaceuticals (CPRX) going to split?
There is no upcoming split for Catalyst Pharmaceuticals.
What sector and industry does Catalyst Pharmaceuticals (CPRX) operate in?
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.